Menu
At Oxymatic®, we offer flexible financing options for clients interested in investing in a hyperbaric chamber, including installment purchases and leasing, tailored to individual client needs and preferences. The company’s team of experts provides support in the financing acquisition process, collaborating with various financial institutions to help choose the best offer. Oxymatic®’s goal is to enable clients to benefit from hyperbaric therapy without financial burden, perfectly suited to your needs
Our team of experts will help you navigate the entire financing acquisition process, whether it’s through installment purchases or leasing. We collaborate with various financial institutions to provide you with access to the best available offers. Our task is to facilitate your decision-making and ensure that the entire process runs smoothly and seamlessly
The OXYMATIC® Mild Hyperbaric Chamber is not a medical device within the meaning of Regulation (EU) 2017/745 of the European Parliament and of the Council of April 5, 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC, in particular, it is not used for: diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation, of disease, injury or disability, including compensation for injury or disability.
© 2020 NOVARTAG GmbH, All Rights Reserved.
NOVARTAG ® and OXYMATIC ® are registered trademarks by NOVARTAG GmbH, GERMANY.
All other trademarks are the property of their respective owners.
Wypełnij formularz kontaktowy, a nasi doradcy skontaktują się z Tobą tak szybko, jak to możliwe.
Please fill out the contact form, and our advisors will get back to you as soon as possible.
